个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
为什么 LogicMark 股价下跌了约 25%;以下是 20 只股票在盘前走势
Gainers
- Axcella Health Inc. (NASDAQ:AXLA) rose 71.7% to $0.7450 in pre-market trading after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue.
- Intelligent Bio Solutions Inc. (NASDAQ:INBS) shares rose 37.6% to $1.41 in pre-market trading. Intelligent Bio Solutions shares jumped 281% on Monday after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.
- Troika Media Group, Inc. (NASDAQ:TRKA) shares rose 29.3% to $0.2399 in pre-market trading after surging 15% on Monday.
- Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) rose 20.5% to $1.41 in pre-market trading. Aridis Pharmaceuticals recently issued AR 501 Phase 2 trial update.
- Evolve Transition Infrastructure LP (NYSE:SNMP) rose 19.5% to $0.2750 in pre-market trading after surging 53% on Monday.
- Helbiz, Inc. (NASDAQ:HLBZ) rose 17.8% to $0.5020 in pre-market trading after jumping 109% on Monday. Helbiz said on Jan. 17, 2023, the company received letter of reprimand from Nasdaq listing qualifications staff.
- HEXO Corp. (NYSE:HEXO) shares rose 14.2% to $1.77 in pre-market trading. HEXO recently regained compliance with Nasdaq minimum bid price requirement.
- Aqua Metals, Inc. (NASDAQ:AQMS) rose 8.4% to $1.53 in pre-market trading. Aqua Metals recently regained compliance with Nasdaq listing requirements.
- Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 6.2% to $3.12 in pre-market trading after dropping 12% on Monday. Bed Bath & Beyond recently received notice from NASDAQ regarding delayed quarterly report.
- Yext, Inc. (NYSE:YEXT) rose 4.5% to $6.99 in pre-market trading after the company announced plans to cut size of the companyâ€s workforce by 8% of full-time employees as a part of its restructuring plan.
Losers
- LogicMark, Inc. (NASDAQ:LGMK) fell 24.7% to $0.2749 in pre-market trading after the company reported pricing of $5.2 million underwritten public offering priced above market.
- Verb Technology Company, Inc. (NASDAQ:VERB) shares fell 20.8% to $0.3075 in pre-market trading after the company reported a proposed underwritten public offering of common stock without warrants.
- Leap Therapeutics, Inc. (NASDAQ:LPTX) fell 14.2% to $0.56 in pre-market trading after declining 9% on Monday. Leap Therapeutics recently agreed to acquire Flame Biosciences Inc, a privately-held biotechnology company, in an all-stock transaction.
- Revelation Biosciences, Inc. (NASDAQ:REVB) fell 7.5% to $0.22 in pre-market trading.
- NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) shares dropped 7.3% to $0.7395 in pre-market trading. NeuroBo Pharmaceuticals recently appointed Joseph Hooker as Interim Chief Executive Officer and President.
- Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) fell 7.1% to $0.52 in pre-market trading. Spectrum Pharmaceuticals recently announced management changes.
- Camber Energy, Inc. (NYSE:CEI) fell 7% to $2.13 in pre-market trading. Camber Energy agreed to acquire renewable diesel facility.
- Greenidge Generation Holdings Inc. (NASDAQ:GREE) fell 6.6% to $0.92 in pre-market after gaining around 6% on Monday.
- Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) shares fell 6.5% to $1.27 in pre-market trading after gaining around 5% on Monday.
- Celyad Oncology SA (NASDAQ:CYAD) fell 5.3% to $1.96 in pre-market trading after gaining around 7% on Monday. Celyad Oncology recently issued an update on its Celyad 2.0 business strategy, which has been adopted and implemented over the last few months.
Now Read This: Markets Turn More Bullish Ahead Of Earnings
Gainers
获胜者
- Axcella Health Inc. (NASDAQ:AXLA) rose 71.7% to $0.7450 in pre-market trading after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue.
- Intelligent Bio Solutions Inc. (NASDAQ:INBS) shares rose 37.6% to $1.41 in pre-market trading. Intelligent Bio Solutions shares jumped 281% on Monday after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.
- Troika Media Group, Inc. (NASDAQ:TRKA) shares rose 29.3% to $0.2399 in pre-market trading after surging 15% on Monday.
- Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) rose 20.5% to $1.41 in pre-market trading. Aridis Pharmaceuticals recently issued AR 501 Phase 2 trial update.
- Evolve Transition Infrastructure LP (NYSE:SNMP) rose 19.5% to $0.2750 in pre-market trading after surging 53% on Monday.
- Helbiz, Inc. (NASDAQ:HLBZ) rose 17.8% to $0.5020 in pre-market trading after jumping 109% on Monday. Helbiz said on Jan. 17, 2023, the company received letter of reprimand from Nasdaq listing qualifications staff.
- HEXO Corp. (NYSE:HEXO) shares rose 14.2% to $1.77 in pre-market trading. HEXO recently regained compliance with Nasdaq minimum bid price requirement.
- Aqua Metals, Inc. (NASDAQ:AQMS) rose 8.4% to $1.53 in pre-market trading. Aqua Metals recently regained compliance with Nasdaq listing requirements.
- Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 6.2% to $3.12 in pre-market trading after dropping 12% on Monday. Bed Bath & Beyond recently received notice from NASDAQ regarding delayed quarterly report.
- Yext, Inc. (NYSE:YEXT) rose 4.5% to $6.99 in pre-market trading after the company announced plans to cut size of the companyâ€s workforce by 8% of full-time employees as a part of its restructuring plan.
- Axcella Health Inc 纳斯达克股票代码:AXLA)在盘前交易中上涨71.7%,至0.7450美元,此前该公司报告了因长期 COVID-19 疲劳而注册 AXA1125 的监管途径。
- 智能生物解决方案公司 纳斯达克股票代码:INBS)股价在盘前交易中上涨37.6%,至1.41美元。周一,Intelligent Bio Solutions的股价上涨了281%,此前该公司宣布成功完成了对Milestone 7业绩的审查,这是其生物传感器平台开发的一个阶段。
- 三驾马车媒体集团有限公司 纳斯达克股票代码:TRKA)股价在周一飙升15%后,在盘前交易中上涨29.3%,至0.2399美元。
- Aridis 制药公司 纳斯达克股票代码:ARDS)在盘前交易中上涨20.5%,至1.41美元。Aridis Pharmicals最近发布了AR 501第二阶段试验更新。
- 发展过渡基础架构 LP 纽约证券交易所代码:SNMP)在周一飙升53%后,在盘前交易中上涨19.5%,至0.2750美元。
- Helbiz, Inc. 纳斯达克股票代码:HLBZ)在周一上涨109%之后,在盘前交易中上涨了17.8%,至0.5020美元。Helbiz表示,2023年1月17日,该公司收到了纳斯达克上市资格工作人员的谴责信。
- HEXO 公司 纽约证券交易所代码:HEXO)股价在盘前交易中上涨14.2%,至1.77美元。HEXO最近恢复了对纳斯达克最低买入价要求的遵守。
- Aqua Metals, Inc 纳斯达克股票代码:AQMS)在盘前交易中上涨8.4%,至1.53美元。Aqua Metals最近恢复了对纳斯达克上市要求的遵守。
- Bed Bath & Beyond 公司 纳斯达克股票代码:BBBY)在周一下跌12%后,在盘前交易中上涨6.2%,至3.12美元。Bed Bath & Beyond最近收到了纳斯达克关于延迟发布季度报告的通知。
- Yext, Inc. 纽约证券交易所代码:YEXT)在盘前交易中上涨4.5%,至6.99美元,此前该公司宣布计划将公司的全职员工人数裁减8%,这是其重组计划的一部分。
Losers
失败者
- LogicMark, Inc. (NASDAQ:LGMK) fell 24.7% to $0.2749 in pre-market trading after the company reported pricing of $5.2 million underwritten public offering priced above market.
- Verb Technology Company, Inc. (NASDAQ:VERB) shares fell 20.8% to $0.3075 in pre-market trading after the company reported a proposed underwritten public offering of common stock without warrants.
- Leap Therapeutics, Inc. (NASDAQ:LPTX) fell 14.2% to $0.56 in pre-market trading after declining 9% on Monday. Leap Therapeutics recently agreed to acquire Flame Biosciences Inc, a privately-held biotechnology company, in an all-stock transaction.
- Revelation Biosciences, Inc. (NASDAQ:REVB) fell 7.5% to $0.22 in pre-market trading.
- NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) shares dropped 7.3% to $0.7395 in pre-market trading. NeuroBo Pharmaceuticals recently appointed Joseph Hooker as Interim Chief Executive Officer and President.
- Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) fell 7.1% to $0.52 in pre-market trading. Spectrum Pharmaceuticals recently announced management changes.
- Camber Energy, Inc. (NYSE:CEI) fell 7% to $2.13 in pre-market trading. Camber Energy agreed to acquire renewable diesel facility.
- Greenidge Generation Holdings Inc. (NASDAQ:GREE) fell 6.6% to $0.92 in pre-market after gaining around 6% on Monday.
- Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) shares fell 6.5% to $1.27 in pre-market trading after gaining around 5% on Monday.
- Celyad Oncology SA (NASDAQ:CYAD) fell 5.3% to $1.96 in pre-market trading after gaining around 7% on Monday. Celyad Oncology recently issued an update on its Celyad 2.0 business strategy, which has been adopted and implemented over the last few months.
- LogicMark, Inc. 纳斯达克股票代码:LGMK)在盘前交易中下跌24.7%,至0.2749美元,此前该公司公布的520万美元承销公开发行定价高于市场。
- Verb Technology, Inc. 纳斯达克股票代码:VERB)股价在盘前交易中下跌20.8%,至0.3075美元,此前该公司报告了拟议的无认股权证普通股的承销公开发行。
- Leap Therapeutics 纳斯达克股票代码:LPTX)在周一下跌9%后,在盘前交易中下跌14.2%,至0.56美元。Leap Therapeutics最近同意以全股交易收购私营生物技术公司Flame Biosciences Inc。
- 启示生物科学公司 纳斯达克股票代码:REVB)在盘前交易中下跌7.5%,至0.22美元。
- NeuroBo 制药有限公司 纳斯达克股票代码:NRBO)股价在盘前交易中下跌7.3%,至0.7395美元。NeuroBo Pharmicals最近任命约瑟夫·胡克为临时首席执行官兼总裁。
- Spectrum 制药有限公司 纳斯达克股票代码:SPPI)在盘前交易中下跌7.1%,至0.52美元。Spectrum制药最近宣布了管理层变动
- 坎伯能源公司 纽约证券交易所代码:CEI)在盘前交易中下跌7%,至2.13美元。坎伯能源公司同意收购可再生柴油设施。
- 格林尼治一代控股有限公司 纳斯达克股票代码:GREE)在周一上涨约6%后,在盘前下跌6.6%,至0.92美元。
- 莱特斯科技控股公司PTV.有限公司 纳斯达克股票代码:LYT)股价在周一上涨约5%后,在盘前交易中下跌6.5%,至1.27美元。
- Celayad Oncolo 纳斯达克股票代码:CYAD)在周一上涨约7%后,在盘前交易中下跌5.3%,至1.96美元。Celyad Oncology最近发布了其Celyad 2.0业务战略的最新信息,该战略在过去几个月中已获得通过和实施。
Now Read This: Markets Turn More Bullish Ahead Of Earnings
现在读这个: 在盈利之前,市场变得更加看涨
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!